跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEFERASIROX TEVA 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DEFERASIROX TEVA 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
DEFERASIROX TEVA 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Teva Pharma S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 23, 2020
Approval ID
e8a2dc7ecb06fdfc
Company
Teva Pharma S.L.U.
Type
Standard
Approval Details
Approval Id
e8a2dc7ecb06fdfc
Drug Cima Aemps Name
DEFERASIROX TEVA 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85516
Holder Company Name
Teva Pharma S.L.U.
Marketing Company Name
Teva Pharma S.L.U.
Authorization Date
2020-10-23
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
360 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Teva Pharma S.L.U.
Active Ingredients
DEFERASIROX
360 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 23, 2020
Approval ID
e8a2dc7ecb06fdfc
Type
Standard
Back to CIMA-AEMPS Approvals